BR112014007491A2 - sequências de aminoácidos para o controle de patógenos - Google Patents
sequências de aminoácidos para o controle de patógenosInfo
- Publication number
- BR112014007491A2 BR112014007491A2 BR112014007491A BR112014007491A BR112014007491A2 BR 112014007491 A2 BR112014007491 A2 BR 112014007491A2 BR 112014007491 A BR112014007491 A BR 112014007491A BR 112014007491 A BR112014007491 A BR 112014007491A BR 112014007491 A2 BR112014007491 A2 BR 112014007491A2
- Authority
- BR
- Brazil
- Prior art keywords
- peptides
- amino acid
- acid sequences
- pathogen control
- bacteria
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/39—Medicinal preparations containing antigens or antibodies characterised by the immunostimulating additives, e.g. chemical adjuvants
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23K—FODDER
- A23K20/00—Accessory food factors for animal feeding-stuffs
- A23K20/10—Organic substances
- A23K20/142—Amino acids; Derivatives thereof
- A23K20/147—Polymeric derivatives, e.g. peptides or proteins
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/1703—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
- A61K38/1706—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from fish
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/10—Antimycotics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/04—Immunostimulants
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
- C07K14/461—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from fish
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
Landscapes
- Life Sciences & Earth Sciences (AREA)
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Zoology (AREA)
- Medicinal Chemistry (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- General Health & Medical Sciences (AREA)
- Polymers & Plastics (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Immunology (AREA)
- Engineering & Computer Science (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Gastroenterology & Hepatology (AREA)
- Oncology (AREA)
- Communicable Diseases (AREA)
- Genetics & Genomics (AREA)
- Toxicology (AREA)
- Biochemistry (AREA)
- Biophysics (AREA)
- Molecular Biology (AREA)
- Food Science & Technology (AREA)
- Animal Husbandry (AREA)
- Epidemiology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Marine Sciences & Fisheries (AREA)
- Microbiology (AREA)
- Mycology (AREA)
- Virology (AREA)
- Peptides Or Proteins (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Fodder In General (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
Abstract
resumo patente de invenção: "sequências de aminoácidos para o controle de patógenos". a presente invenção se refere a peptídios antimicrobianos, isolados e purificados a partir de extratos de brânquias de tilápia (oreochromis niloticus). os referidos peptídios podem ser produzidos por síntese química ou em sistemas de expressão heterólogos, como bactérias e leveduras, por técnicas convencionais de biologia molecular. esses peptídios mostram atividade antimicrobiana contra diversos organismos, entre eles bactérias gram-positivas, bactérias gram-negativas, fungos e vírus. a invenção também inclui composições para o controle de agentes patogênicos que compreendem esses peptídios antimicrobianos. o uso dos referidos peptídios em preparações vacinais, como adjuvante molecular, também faz parte da invenção. 20871455v1
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CU2011-0181 | 2011-09-30 | ||
CU20110181A CU24076B1 (es) | 2011-09-30 | 2011-09-30 | Composición para el control de patógenos |
PCT/CU2012/000005 WO2013044890A1 (es) | 2011-09-30 | 2012-10-01 | Secuencias de aminoácidos para el control de patógenos |
Publications (2)
Publication Number | Publication Date |
---|---|
BR112014007491A2 true BR112014007491A2 (pt) | 2017-04-04 |
BR112014007491B1 BR112014007491B1 (pt) | 2022-03-03 |
Family
ID=47143463
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
BR112014007491-7A BR112014007491B1 (pt) | 2011-09-30 | 2012-10-01 | Composição de vacina e usos de um peptídeo |
Country Status (16)
Country | Link |
---|---|
US (1) | US9549978B2 (pt) |
EP (1) | EP2767290B1 (pt) |
JP (1) | JP6034385B2 (pt) |
KR (1) | KR101986358B1 (pt) |
CN (1) | CN103874502B (pt) |
AR (1) | AR088176A1 (pt) |
AU (1) | AU2012315083B2 (pt) |
BR (1) | BR112014007491B1 (pt) |
CA (1) | CA2849040C (pt) |
CL (1) | CL2014000760A1 (pt) |
CU (1) | CU24076B1 (pt) |
ES (1) | ES2600903T3 (pt) |
MX (1) | MX348934B (pt) |
RU (1) | RU2636001C2 (pt) |
WO (1) | WO2013044890A1 (pt) |
ZA (1) | ZA201402171B (pt) |
Families Citing this family (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN104262485B (zh) * | 2014-04-15 | 2017-01-18 | 四川农业大学 | 罗非鱼sIgM截短重链恒定区蛋白多克隆抗体及其制备方法 |
CN105061575B (zh) * | 2015-02-03 | 2020-08-04 | 浙江海洋学院 | 一种金枪鱼肝脏抗菌肽及其制备方法和用途 |
CN109350731A (zh) * | 2018-12-18 | 2019-02-19 | 汕尾市维明生物科技股份有限公司 | 一种罗非鱼蛋白肽在制备免疫制剂中的应用 |
CN112979763A (zh) * | 2021-03-03 | 2021-06-18 | 山东大学 | 一种基于可溶性疏水载体抗菌肽Oreoch-2的液相合成方法 |
Family Cites Families (15)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20030056244A1 (en) * | 2000-05-02 | 2003-03-20 | Ning Huang | Feed additive compositions and methods |
US6753407B2 (en) * | 2000-08-15 | 2004-06-22 | North Carolina State University | Antimicrobial peptides isolated from fish |
AU2001287178A1 (en) * | 2000-08-15 | 2002-02-25 | North Carolina State University | Antimicrobial peptides isolated from mast cells |
AU2003260224A1 (en) * | 2002-08-22 | 2004-03-11 | Ca Nat Research Council | A genomic approach to identification of novel broad-spectrum antimicrobial peptides from bony fish |
CN101111256B (zh) * | 2004-12-15 | 2012-04-25 | 科罗拉多大学 | 抗菌肽及其使用方法 |
RU2302467C1 (ru) * | 2005-12-01 | 2007-07-10 | Институт биоорганической химии им. академиков М.М. Шемякина и Ю.А. Овчинникова Российской академии наук | Пептиды латарцины, проявляющие антимикробную активность |
AU2006342608A1 (en) * | 2006-04-25 | 2007-11-01 | Intercell Ag | HCV vaccinations |
TWI299335B (en) * | 2006-12-05 | 2008-08-01 | Academia Sinica | Anti-microbal peptides and uses thereof |
WO2009149554A1 (en) * | 2008-06-11 | 2009-12-17 | National Research Council Of Canada | Antimicrobial components of the mucus and extruded slime of hagfish (myxine glutinosa) |
US20110288011A1 (en) * | 2008-12-05 | 2011-11-24 | Jean-Paul Castaigne | Peptide therapeutic conjugates and uses thereof |
WO2010080836A2 (en) * | 2009-01-06 | 2010-07-15 | C3 Jian, Inc. | Antibacterial and antifungal peptides |
WO2010091294A2 (en) * | 2009-02-05 | 2010-08-12 | The Regents Of The University Of California | New targeted antimicrobial moieties |
CN101559214A (zh) * | 2009-05-27 | 2009-10-21 | 珍奥集团股份有限公司 | 具有增强免疫功能作用的组合物及其用途 |
CN102021172A (zh) * | 2010-06-23 | 2011-04-20 | 广西壮族自治区水产研究所 | 罗非鱼白细胞 cAMP 诱导早期抑制因子基因序列及用途 |
KR20140039157A (ko) * | 2011-01-07 | 2014-04-01 | 발리언트 바이오파마 에스디엔 비에이치디 | 항미생물성 융합 화합물 및 그의 용도 |
-
2011
- 2011-09-30 CU CU20110181A patent/CU24076B1/es active IP Right Grant
-
2012
- 2012-09-27 AR ARP120103606A patent/AR088176A1/es unknown
- 2012-10-01 ES ES12783080.0T patent/ES2600903T3/es active Active
- 2012-10-01 AU AU2012315083A patent/AU2012315083B2/en active Active
- 2012-10-01 MX MX2014003892A patent/MX348934B/es active IP Right Grant
- 2012-10-01 BR BR112014007491-7A patent/BR112014007491B1/pt active IP Right Grant
- 2012-10-01 EP EP12783080.0A patent/EP2767290B1/en active Active
- 2012-10-01 KR KR1020147009805A patent/KR101986358B1/ko active IP Right Grant
- 2012-10-01 RU RU2014117659A patent/RU2636001C2/ru active
- 2012-10-01 CA CA2849040A patent/CA2849040C/en active Active
- 2012-10-01 WO PCT/CU2012/000005 patent/WO2013044890A1/es active Application Filing
- 2012-10-01 CN CN201280050943.4A patent/CN103874502B/zh active Active
- 2012-10-01 JP JP2014532244A patent/JP6034385B2/ja active Active
- 2012-10-01 US US14/346,562 patent/US9549978B2/en active Active
-
2014
- 2014-03-24 ZA ZA2014/02171A patent/ZA201402171B/en unknown
- 2014-03-27 CL CL2014000760A patent/CL2014000760A1/es unknown
Also Published As
Publication number | Publication date |
---|---|
EP2767290B1 (en) | 2016-09-14 |
RU2636001C2 (ru) | 2017-11-17 |
MX348934B (es) | 2017-07-03 |
ES2600903T3 (es) | 2017-02-13 |
EP2767290A1 (en) | 2014-08-20 |
CU24076B1 (es) | 2015-01-29 |
KR20140070597A (ko) | 2014-06-10 |
US9549978B2 (en) | 2017-01-24 |
BR112014007491B1 (pt) | 2022-03-03 |
ZA201402171B (en) | 2015-12-23 |
CA2849040A1 (en) | 2013-04-04 |
AU2012315083B2 (en) | 2016-02-25 |
MX2014003892A (es) | 2014-07-09 |
AR088176A1 (es) | 2014-05-14 |
JP2014533931A (ja) | 2014-12-18 |
JP6034385B2 (ja) | 2016-11-30 |
WO2013044890A1 (es) | 2013-04-04 |
RU2014117659A (ru) | 2015-11-10 |
CU20110181A7 (es) | 2013-05-31 |
KR101986358B1 (ko) | 2019-06-05 |
CN103874502B (zh) | 2015-11-25 |
CL2014000760A1 (es) | 2014-08-22 |
CN103874502A (zh) | 2014-06-18 |
AU2012315083A1 (en) | 2014-05-08 |
US20140294871A1 (en) | 2014-10-02 |
CA2849040C (en) | 2019-11-26 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CL2018002825A1 (es) | Vacuna contra vrs | |
BR112015014458A2 (pt) | derivados de manose para o tratamento de infecções bacterianas | |
ATE494906T1 (de) | Von zellen stammende virale impfstoffe mit geringen mengen an rest-zell-dna | |
BR112015016001A2 (pt) | compostos, composições farmacêuticas e respectivos usos e método para tratar ou prevenir infecção bacteriana | |
BR112013030894A2 (pt) | moduladores do sistema imune | |
BR112013003439A2 (pt) | "inibidores de oxadiazol de produção de leucotrieno" | |
WO2007022425A3 (en) | Influenza recombinant subunit vaccine | |
BR112014026058A2 (pt) | composições para tratamento tópico de infecções microbianas | |
BRPI0907087A2 (pt) | ácidos nucleicos de fórmula (i) (nuglxmgnnv)a e derivados dos mesmos como um agente imunoestimulante/adjuvante | |
DK2280721T3 (da) | Indoleamin-2, 3-dioxygenasebaseret immunterapi | |
WO2011110655A3 (en) | Immunogenic composition or vaccine against gram - negative bacterial, for example neiserial, infection or disease | |
MX359517B (es) | Composiciones, formulaciones y metodos de compuestos lipidicos modificadores de respuestas inmunitaria. | |
EA201490610A1 (ru) | Соединения и способы усиления врожденных иммунных ответов | |
NZ607580A (en) | N-heteroaryl compounds | |
BR112014002958A2 (pt) | "3,4-di-hidro-1h-[1,8]naftiridinonas substituídas com piperidinila antibacterianas, composição farmacêutica compreendendo os referidos compostos, processos para preparação destes e uso". | |
BR112014001409A2 (pt) | métodos e composições para vacinação contra staphylococcus aureus | |
BR112014007491A2 (pt) | sequências de aminoácidos para o controle de patógenos | |
BR112014011345A2 (pt) | partículas tipo vírus da influenza (vlps) compreendendo nicotiana tabacum produzida por hemaglutinina | |
WO2012054907A3 (en) | Novel hemagglutinin 5 (h5) proteins for the treatment and prevention of influenza infections | |
BR112014003278A2 (pt) | vacinas para influenza h5 | |
BR112015013625A2 (pt) | adjuvante de vacinação, preparação e vacinas contendo o mesmo | |
WO2012073257A3 (en) | Vaccine formulation for prophylaxis and treatment of chandipura virus infections in mammals | |
WO2011045573A3 (en) | Staphylococcal antigens | |
ATE420658T1 (de) | Imidazoquinolinamine als adjuvantien für hiv dna vakzine | |
BR112013023354A2 (pt) | vacina para rinite equina |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
B07D | Technical examination (opinion) related to article 229 of industrial property law [chapter 7.4 patent gazette] | ||
B06F | Objections, documents and/or translations needed after an examination request according [chapter 6.6 patent gazette] | ||
B07E | Notification of approval relating to section 229 industrial property law [chapter 7.5 patent gazette] |
Free format text: NOTIFICACAO DE ANUENCIA RELACIONADA COM O ART 229 DA LPI |
|
B06U | Preliminary requirement: requests with searches performed by other patent offices: procedure suspended [chapter 6.21 patent gazette] | ||
B07A | Application suspended after technical examination (opinion) [chapter 7.1 patent gazette] | ||
B06A | Patent application procedure suspended [chapter 6.1 patent gazette] | ||
B09A | Decision: intention to grant [chapter 9.1 patent gazette] | ||
B16A | Patent or certificate of addition of invention granted [chapter 16.1 patent gazette] |
Free format text: PRAZO DE VALIDADE: 20 (VINTE) ANOS CONTADOS A PARTIR DE 01/10/2012, OBSERVADAS AS CONDICOES LEGAIS. |